S-2-amino-5-(2-nitroimidazol-1-yl) pentanoic acid: A potential bioreductively-activated inhibitor of nitric oxide synthase activity for use in cancer therapy

被引：0
|
作者：
Ulhaq, S [1 ]
Naylor, MA [1 ]
Threadgill, MD [1 ]
Chinje, E [1 ]
Stratford, IJ [1 ]
机构：
[1] MRC,RADIOBIOL UNIT,CHILTON OX11 0RD,OXON,ENGLAND
来源：
BIOLOGY OF NITRIC OXIDE, PT 5 | 1996年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 28 条
  • [1] S-2-amino-5-(2-nitroimidazol-1-yl)pentanoic acid: A model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activity
    Ulhaq, S
    Naylor, MA
    Chinje, EC
    Threadgill, MD
    Stratford, IJ
    ANTI-CANCER DRUG DESIGN, 1997, 12 (01): : 61 - 65
  • [2] Mechanism of Inactivation of Neuronal Nitric Oxide Synthase by (S)-2-Amino-5-(2-(methylthio)acetimidamido)pentanoic Acid
    Tang, Wei
    Li, Huiying
    Doud, Emma H.
    Chen, Yunqiu
    Choing, Stephanie
    Plaza, Carla
    Kelleher, Neil L.
    Poulos, Thomas L.
    Silverman, Richard B.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (18) : 5980 - 5989
  • [3] Inactivation Mechanism of Neuronal Nitric Oxide Synthase by (S)-2-Amino-5-(2-(methylthio)acetimidamido)pentanoic Acid: Chemical Conversion of the Inactivator in the Active Site
    Yan, Lijuan
    Wang, Yijing
    Zhang, Shiqing
    Li, Xinyi
    Wei, Jingjing
    Wang, Zhiguo
    Liu, Yongjun
    INORGANIC CHEMISTRY, 2021, 60 (13) : 9345 - 9358
  • [4] Syntheses of new conformationally constrained S-[2-[(1-iminoethyl)amino]ethyl]homocysteine derivatives as potential nitric oxide synthase inhibitors
    Wang, LJ
    Grapperhaus, ML
    Pitzele, BS
    Hagen, TJ
    Fok, KF
    Scholten, JA
    Spangler, DP
    Toth, MV
    Jerome, GM
    Moore, WM
    Manning, PT
    Sikorski, JA
    HETEROATOM CHEMISTRY, 2002, 13 (01) : 77 - 83
  • [5] Asymmetric synthesis and stereochemical structure-activity relationship of (R)- and (S)-8-[1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethoxy] octanoic acid heptyl ester, a potent inhibitor of allene oxide synthase
    Oh, Kelmel
    Shimura, Yolchiro
    Ishikawa, Kyoko
    Ito, Yudai
    Asami, Tadao
    Murofushi, Noboru
    Yoshizawa, Yuko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (03) : 1090 - 1095
  • [6] Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
    af Rosenschold, Magnus Munck
    Johannesson, Petra
    Nikitidis, Antonios
    Tyrchan, Christian
    Chang, Hui-Fang
    Ronn, Robert
    Chapman, Dave
    Ullah, Victoria
    Nikitidis, Grigorios
    Glader, Pernilla
    Kack, Helena
    Bonn, Britta
    Wagberg, Fredrik
    Bjorkstrand, Eva
    Andersson, Ulf
    Swedin, Linda
    Rohman, Mattias
    Andreasson, Theresa
    Bergstrom, Eva Lamm
    Jiang, Fanyi
    Zhou, Xiao-Hong
    Lundqvist, Anders J.
    Malmberg, Anna
    Ek, Margareta
    Gordon, Euan
    Pettersen, Anna
    Ripa, Lena
    Davis, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) : 7769 - 7787
  • [7] The Inhibition of Oxidative Stress-Mediated Cell Apoptosis by the Caspase Inhibitor (S)-3-((S)-2-(6-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-oxoisoindolin-2-yl)butanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic Acid in Human Dermal Papilla Cells
    Park, Bomi
    Kim, Daeun
    Lee, Yurim
    Choi, Seihyun
    Park, Heedong
    Lee, Sanghwa
    Hwang, Jaesung
    COSMETICS, 2024, 11 (04)
  • [8] Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice
    Desjardins, J
    Emerson, DL
    Colagiovanni, DB
    Abbott, E
    Brown, EN
    Drolet, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03): : 894 - 902
  • [9] Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl) thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine
    Annedi, Subhash C.
    Maddaford, Shawn P.
    Ramnauth, Jailall
    Renton, Paul
    Rybak, Taras
    Silverman, Sarah
    Rakhit, Suman
    Mladenova, Gabriela
    Dove, Peter
    Andrews, John S.
    Zhang, Dongqin
    Porreca, Frank
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 94 - 107
  • [10] Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents
    Inagaki, H
    Miyauchi, S
    Miyauchi, RN
    Kawato, HC
    Ohki, H
    Matsuhashi, N
    Kawakami, K
    Takahashi, H
    Takemura, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) : 1005 - 1015
123